Cargando…

Mpox Person-to-Person Transmission—Where Have We Got So Far? A Systematic Review

The recent multi-country outbreak of Mpox (Monkeypox disease) constituted a public health emergency. Although animal-to-human transmission is known to be the primary way of transmission, an increasing number of cases transmitted by person-to-person contact have been reported. During the recent Mpox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, Pedro, Costa, Miguel Alves, Gonçalves, Micael F. M., Rodrigues, Acácio Gonçalves, Lisboa, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222665/ https://www.ncbi.nlm.nih.gov/pubmed/37243160 http://dx.doi.org/10.3390/v15051074

Ejemplares similares

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020)

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
por: Turnbull, Samantha, et al.
Publicado: (2015)

The sex life of male patients with cirrhosis and its organic factors: What we have got so far?
por: Darmadi, Darmadi, et al.
Publicado: (2023)

Imaging of the unstable plaque: how far have we got?
por: Matter, Christian M., et al.
Publicado: (2009)

Diagnosing acute compartment syndrome—where have we got to?
por: McMillan, Tristan E., et al.
Publicado: (2019)

Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2022)

OBHDP Editorial: Where we are, how we got here, and where we’re going
por: Kouchaki, Maryam
Publicado: (2020)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

The Endothelial Glycocalyx as a Target of Ischemia and Reperfusion Injury in Kidney Transplantation—Where Have We Gone So Far?
por: Duni, Anila, et al.
Publicado: (2021)

Biomaterials for Testicular Bioengineering: How far have we come and where do we have to go?
por: Horvath-Pereira, Bianca de Oliveira, et al.
Publicado: (2023)

Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
por: Abdulmawjood, Bilal, et al.
Publicado: (2021)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

What have we learnt so far from COVID-19?
por: Doherty, Peter C.
Publicado: (2021)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

COVID-19 and the heart: what we have learnt so far
por: Shaha, Kunal Bikram, et al.
Publicado: (2020)

Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
por: Bennardo, Luigi, et al.
Publicado: (2021)

Biologics in COVID-19 So Far: Systematic Review
por: Arias, Milton, et al.
Publicado: (2022)

Monkeypox transmission—what we know so far
por: Venkatesan, Priya
Publicado: (2022)

Multisystem inflammatory syndrome in children and complete atrioventricular block: What have we learned so far and where do we go from here?
por: Clark, Bradley C, et al.
Publicado: (2021)

Cancer genomics just got personal
por: Marszalek, Rafal T
Publicado: (2014)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Cellular and Molecular Pathophysiology of Traumatic Brain Injury: What Have We Learned So Far?
por: Freire, Marco Aurelio M., et al.
Publicado: (2023)

What we know so far
Publicado: (2021)

Modeling Water Resources: Have We Got it Right?
por: Havens, Karl E.
Publicado: (2001)

Microbiome in Male Genital Mucosa (Prepuce, Glans, and Coronal Sulcus): A Systematic Review
por: Gonçalves, Micael F. M., et al.
Publicado: (2022)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m81ofnpt0nbba51lvg5hlbth4h